Multiple Myeloma Medicines: Affordable Generic Treatments
Multiple myeloma is a cancer of plasma cells in the bone marrow. OnlineMeds offers FDA-approved generic medications used to treat multiple myeloma, including proteasome inhibitors, immunomodulatory drugs (IMiDs), and monoclonal antibodies—at 85–90% savings compared to branded versions.
Our Multiple Myeloma Treatment Options
- Lenalidomide (Revlimid) — Immunomodulatory agent for newly diagnosed and relapsed/refractory myeloma
- Bortezomib (Velcade) — Proteasome inhibitor for induction and maintenance therapy
- Pomalidomide (Pomalyst) — IMiD for patients with lenalidomide-refractory disease
- Dexamethasone — Corticosteroid used in combination regimens
- Thalidomide — IMiD for newly diagnosed and relapsed myeloma
How These Medicines Work
Multiple myeloma treatments work through several mechanisms: proteasome inhibitors (bortezomib) prevent cancer cell proliferation by blocking protein degradation; immunomodulatory drugs (lenalidomide, pomalidomide) enhance immune recognition of myeloma cells; and corticosteroids reduce inflammation and support immune response.
Why Choose OnlineMeds for Myeloma Medications?
- FDA-approved generic medicines from trusted manufacturers
- Save 85–90% on multiple myeloma treatments
- Prescription support and guidance at checkout
- Discreet, secure international shipping
- Customer reviews and clinical transparency
Frequently Asked Questions
Q: Are generic multiple myeloma medicines as effective as branded versions?
A: Yes. Generic medications contain identical active ingredients and undergo the same FDA approval standards as branded drugs. They are bioequivalent and work the same way in your body.
Q: How long does shipping take?
A: We offer several shipping options. Standard international shipping typically takes 7–14 business days. Express options are available at checkout.
Q: Do I need a valid prescription?
A: Yes. Multiple myeloma medications are prescription-only. You can upload your prescription at checkout, and our pharmacists will verify it.
Q: Can I combine multiple myeloma drugs?
A: Treatment protocols often use combination therapy (e.g., bortezomib + lenalidomide + dexamethasone). Always follow your physician’s prescribed regimen. Our team can help verify your medication list.
Q: What if my myeloma becomes resistant to one drug?
A: Multiple myeloma may develop resistance over time. Work with your oncologist to adjust your regimen. We stock a full range of IMiDs, proteasome inhibitors, and supportive medications.
Q: Are there side effects I should know about?
A: Myeloma medications can cause fatigue, neuropathy, and liver changes. Your doctor will monitor you closely. We provide patient information sheets and support resources with every order.
Medical Disclaimer
This content is for informational purposes only and is not intended as medical advice, diagnosis, or treatment. Multiple myeloma is a serious condition requiring supervision by a qualified oncologist. Always use myeloma medicines as prescribed by a licensed medical professional. If you have questions about your specific treatment plan, consult your doctor or pharmacist.